268 related articles for article (PubMed ID: 12504054)
1. How low is the alpha/beta ratio for prostate cancer?
Wang JZ; Guerrero M; Li XA
Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):194-203. PubMed ID: 12504054
[TBL] [Abstract][Full Text] [Related]
2. The low alpha/beta ratio for prostate cancer: what does the clinical outcome of HDR brachytherapy tell us?
Wang JZ; Li XA; Yu CX; DiBiase SJ
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1101-8. PubMed ID: 14575842
[TBL] [Abstract][Full Text] [Related]
3. Impact of tumor repopulation on radiotherapy planning.
Wang JZ; Li XA
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):220-7. PubMed ID: 15629615
[TBL] [Abstract][Full Text] [Related]
4. Comparison of in vitro and in vivo alpha/beta ratios for prostate cancer.
Carlson DJ; Stewart RD; Li XA; Jennings K; Wang JZ; Guerrero M
Phys Med Biol; 2004 Oct; 49(19):4477-91. PubMed ID: 15552412
[TBL] [Abstract][Full Text] [Related]
5. Optimal radiotherapy for prostate cancer: predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models.
King CR; DiPetrillo TA; Wazer DE
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):165-72. PubMed ID: 10656389
[TBL] [Abstract][Full Text] [Related]
6. Analysis of a large number of clinical studies for breast cancer radiotherapy: estimation of radiobiological parameters for treatment planning.
Guerrero M; Li XA
Phys Med Biol; 2003 Oct; 48(20):3307-26. PubMed ID: 14620060
[TBL] [Abstract][Full Text] [Related]
7. Impact of prolonged fraction delivery times on tumor control: a note of caution for intensity-modulated radiation therapy (IMRT).
Wang JZ; Li XA; D'Souza WD; Stewart RD
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):543-52. PubMed ID: 12957268
[TBL] [Abstract][Full Text] [Related]
8. How low is the alpha/beta ratio for prostate cancer?
Kal HB; Van Gellekom MP
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1116-21. PubMed ID: 14575844
[TBL] [Abstract][Full Text] [Related]
9. Estimation of a self-consistent set of radiobiological parameters from hypofractionated versus standard radiation therapy of prostate cancer.
Pedicini P; Strigari L; Benassi M
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e231-7. PubMed ID: 23332226
[TBL] [Abstract][Full Text] [Related]
10. What hypofractionated protocols should be tested for prostate cancer?
Fowler JF; Ritter MA; Chappell RJ; Brenner DJ
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1093-104. PubMed ID: 12829147
[TBL] [Abstract][Full Text] [Related]
11. Is alpha/beta for prostate tumors really low?
Fowler J; Chappell R; Ritter M
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):1021-31. PubMed ID: 11429230
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of incomplete repair parameters for rat spinal cord: the feasibility of large doses per fraction in PDR and HDR brachytherapy.
Pop LA; Millar WT; Visser AG; van der Kogel AJ
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):215-26. PubMed ID: 11516872
[TBL] [Abstract][Full Text] [Related]
13. Dose escalation to combat hypoxia in prostate cancer: a radiobiological study on clinical data.
Wang JZ; Li XA; Mayr NA
Br J Radiol; 2006 Nov; 79(947):905-11. PubMed ID: 16885177
[TBL] [Abstract][Full Text] [Related]
14. Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the alpha/beta ratio.
Nahum AE; Movsas B; Horwitz EM; Stobbe CC; Chapman JD
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):391-401. PubMed ID: 12957250
[TBL] [Abstract][Full Text] [Related]
15. Effect of heterogeneity in radiosensitivity on LQ based isoeffect formalism for low alpha/beta cancers.
Moiseenko V
Acta Oncol; 2004; 43(5):499-502. PubMed ID: 15360056
[TBL] [Abstract][Full Text] [Related]
16. In vitro determination of radiation sensitivity parameters for DU-145 prostate cancer cells.
Wang JZ; Rhee JG; Shi P; Stewart RD; Allen Li X
Int J Radiat Biol; 2008 Jun; 84(6):515-22. PubMed ID: 18470750
[TBL] [Abstract][Full Text] [Related]
17. Effect of edema, relative biological effectiveness, and dose heterogeneity on prostate brachytherapy.
Wang JZ; Mayr NA; Nag S; Montebello J; Gupta N; Samsami N; Kanellitsas C
Med Phys; 2006 Apr; 33(4):1025-32. PubMed ID: 16696479
[TBL] [Abstract][Full Text] [Related]
18. Loss of radiobiological effect of imaging dose in image guided radiotherapy due to prolonged imaging-to-treatment times.
Flynn RT
Med Phys; 2010 Jun; 37(6):2761-9. PubMed ID: 20632586
[TBL] [Abstract][Full Text] [Related]
19. High-dose-rate brachytherapy as monotherapy for prostate cancer: The impact of cellular repair and source decay.
Tien CJ; Carlson DJ; Nath R; Chen ZJ
Brachytherapy; 2019; 18(5):701-710. PubMed ID: 31109870
[TBL] [Abstract][Full Text] [Related]
20. Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry.
Dicker AP; Lin CC; Leeper DB; Waterman FM
Semin Urol Oncol; 2000 May; 18(2):152-9. PubMed ID: 10875458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
